The Mount Sinai Medical Center Becomes a 2009 EPA Region 2 Quality Award Recipient
This annual Environmental Protection Agency award honors individuals and organizations who have contributed significantly to the improvement of the environment.
The Mount Sinai Medical Center has been selected as a 2009 USEPA-Region 2 Environmental Quality Award recipient in the Non-Profit Organization, Environmental or Community Group category. This annual award honors individuals and organizations who have contributed significantly to improving the environment.
Mount Sinai submitted the award application in February, citing progress in the management of hazardous materials and the work of Dr Philip Landrigan, Professor and Chair of the Department of Community and Preventive Medicine and Director of the Children's Environmental Health Center at Mount Sinai School of Medicine, as it pertains to the Community and Preventive Medicine.
I am delighted that Mount Sinai was selected for this award, said Dr Philip Landrigan. "We have created the nation's largest program in children's environmental health because it is urgently important to discover the preventable environmental causes of disease in America’s children and then to turn those discoveries into a blueprint for prevention."
The Award Ceremony took place on April 24, 2009, at the USEPA’s Regional Headquarters in Manhattan. The honor is given to those individuals or organizations that have made significant contributions to improving the environment and public health in EPA Region 2, which covers New York, New Jersey, Puerto Rico, the U.S. Virgin Islands and seven federally-recognized Indian Nations. The Agency receives nominations for the awards from both inside and outside EPA.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.
Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic-science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.